Webster Bank’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Webster Bank’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,527	Closed	-$18.8K	–	595
2023 Q3	$18.8K	Hold	1,527	–	–	﹤0.01%	406
2023 Q2	$18.8K	Hold	1,527	–	–	﹤0.01%	406
2023 Q1	$18.8K	Hold	1,527	–	–	﹤0.01%	419
2022 Q4	$17K	Sell	1,527 -1,528	-50%	-$12.6K	﹤0.01%	430
2022 Q3	$11K	Hold	3,055	–	–	﹤0.01%	449
2022 Q2	$18K	Hold	3,055	–	–	﹤0.01%	416
2022 Q1	$19K	Hold	3,055	–	–	﹤0.01%	432
2021 Q4	$12K	Hold	3,055	–	–	﹤0.01%	480
2021 Q3	$15K	Hold	3,055	–	–	﹤0.01%	450
2021 Q2	$20K	Hold	3,055	–	–	﹤0.01%	412
2021 Q1	$19K	Hold	3,055	–	–	﹤0.01%	421
2020 Q4	$21K	Hold	3,055	–	–	﹤0.01%	395
2020 Q3	$12K	Hold	3,055	–	–	﹤0.01%	415
2020 Q2	$10K	Hold	3,055	–	–	﹤0.01%	421
2020 Q1	$7K	Hold	3,055	–	–	﹤0.01%	433
2019 Q4	$10K	Hold	3,055	–	–	﹤0.01%	449
2019 Q3	$14K	Sell	3,055 -828	-21%	-$4.14K	﹤0.01%	415
2019 Q2	$18K	Hold	3,883	–	–	﹤0.01%	403
2019 Q1	$21K	Hold	3,883	–	–	﹤0.01%	389
2018 Q4	$12K	Hold	3,883	–	–	﹤0.01%	408
2018 Q3	$16K	Hold	3,883	–	–	﹤0.01%	421
2018 Q2	$15K	Hold	3,883	–	–	﹤0.01%	423
2018 Q1	$25K	Hold	3,883	–	–	﹤0.01%	415
2017 Q4	$31K	Buy	+3,883	New	+$36.2K	﹤0.01%	424
2017 Q3	–	Sell	-3,883	Closed	-$38K	–	563
2017 Q2	$38K	Hold	3,883	–	–	0.01%	384
2017 Q1	$94K	Buy	+3,883	New	+$97.2K	0.01%	293

Other funds holding MACK

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $1.84B AUM 18.57% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Webster Bank's MACK Position: Q4 2023 in Review

Webster Bank sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2023, closing a stake of 1,527 shares — an estimated $18.8K sold.

Webster Bank first reported a position in MACK in Q1 2017 and held it in 26 quarters. The position peaked at $94K in Q1 2017. 67 funds tracked by Wall St. Rank hold MACK as of Q4 2023.

Webster Bank reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Webster Bank sold 1,527 Merrimack Pharmaceuticals, Inc. shares in Q4 2023, an estimated $18.8K.
Webster Bank first reported a position in Merrimack Pharmaceuticals, Inc. in Q1 2017 and held it in 26 quarters.
Webster Bank's Merrimack Pharmaceuticals, Inc. position peaked at $94K in Q1 2017.
67 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2023.

Based on Webster Bank's 13F filing for Q4 2023, filed 23 Jan 2024.